Chronic childhood idiopathic thrombocytopenic purpura
Related Experiment Video
Updated: Oct 11, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
1Royal London Hospital, Whitechapel, UK.
Insights
Childhood idiopathic thrombocytopenic purpura (ITP) is usually mild, with most children recovering spontaneously. However, rare cases require careful management due to low platelet counts and potential treatment risks.
Area of Science:
- Pediatrics
- Hematology
- Immunology
Background:
- Childhood idiopathic thrombocytopenic purpura (ITP) affects children, with over 95% experiencing spontaneous recovery.
- A small subset of children develop chronic ITP with persistent low platelet counts and symptoms.
Purpose of the Study:
- To evaluate the management challenges and treatment efficacy for childhood ITP.
- To highlight the difficulties in risk:benefit assessment for ITP treatment.
Main Methods:
- Review of existing literature on childhood ITP management.
- Analysis of treatment outcomes and risks associated with various therapeutic regimens.
- Discussion of the need for improved epidemiological data and clinical trials.
Main Results:
- Most childhood ITP cases resolve without intervention.
- Splenectomy is effective but carries significant risks and is irreversible.
- Many alternative treatments are ineffective or toxic.
Conclusions:
- Management of chronic childhood ITP requires careful risk-benefit appraisal.
- Inadequate data and lack of large-scale trials impede optimal patient management.
- International collaboration is needed to improve understanding and treatment of rare ITP cases.
Abstract:
Childhood idiopathic thrombocytopenic purpura (ITP) is a largely trivial disorder from which over 95% of children sooner or later recover spontaneously, and for most of whom the risks of unnecessary or ineffective therapy are arguably greater than those of the untreated disease. There are, however, a few patients who continue to have very low platelet counts and remain symptomatic for many months or years. They are rare, and they present difficult management problems. Splenectomy is probably the most effective treatment but is also the most dangerous and is not always successful. It is also irreversible. Most other regimens are either ineffective, unacceptably toxic, or both. Planning management for an individual patient requires a realistic risk:benefit appraisal, a process that is impeded by inadequate epidemiological data and a scarcity of large-scale randomized clinical trials. International collaborative studies may help in the future.
Related Concept Videos
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:25Chronic Pancreatitis I: Introduction
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Venous Thrombosis III: Interprofessional Care